PsyIndex Weekly Update September 21, 2020 – September 25, 2020

The PsyIndex rose 35.84% last week following the listing of COMPASS Pathways Inc. (NASDAQ: CMPS) that soared nearly 50% in its first week. The move also helped boost several other psychedelic stocks.


Weekly Performance: $110.15 (+35.84%)


Top Gainers

Top Decliners


Corporate News, Deals & Listings

  • PharmaDrug Inc. recently closed its acquisition of a retail establishment specializing in the sale of psychedelic products. via CannabisFN
  • Numinus Wellness Inc. began cultivating mushrooms for the purpose of psilocybin production at its 7,000 sq. ft. licensed facility. via CannabisFN
  • Mydecine Innovations Group Inc. announced that its Mindleap Health subsidiary launched the world’s first telehealth platform for psychedelic integration. via CannabisFN
  • Mind Cure Health Inc. added Alain Roy as Product Development Specialist to its team and received Health Canada authorization to sell its Moonbeam Mushroom products in Canada. via CannabisFN
  • Havn Life Sciences Inc. recently submitted a range of natural health products to Health Canada for approval. via CannabisFN
  • MindMed, currently listed on the NEO, announced plans for NASDAQ up-listing. via Forbes


Featured Content


Pure Extracts: A Prove Extraction Company with Laser Focus

We take a look at Pure Extract Technologies Inc. (CSE: PULL) (listing pending) and why investors interested in operational excellence may want to take a closer look.


How the Psybrary™ Could Revolutionize Psychedelic Drug Discovery

We take a look at MagicMed’s Psybrary™, the current stage of development and how it could revolutionize psychedelic drug discovery.


Previously Announced Upcoming Listings

  • Field Trip Psychedelics Inc. announced a letter of intent with Newton Energy Corporation (TSX.V: NTN.H). In addition, the company plans to complete a brokered private placement of common shares at a price of $2.00 per common share for gross proceeds of between $14 million and $15 million.
  • Silo Wellness Inc. announced a proposed reverse takeover with Yukoterre Resources Inc. (CSE: YT). In connection with the transaction, the company will complete a private placement for gross proceeds of approximately $2.5 million.
  • Entheon Biomedical Corp. announced a definitive amalgamation agreement with MPV Exploration Inc. to list on the CSE. In conjunction, it will complete a non-brokered private placement of subscription receipts to raise C$2 million in working capital.
  • Novamind Ventures Inc. signed a letter of intent with Hinterland Metals Inc. and undertook a $3 million non-brokered private placement to go public on the Canadian Securities Exchange (CSE).
  • Mindset Pharma Inc. signed a letter of intent with North Sur Resources Inc. and aims to raise $1 million in a private placement to go public on the Canadian Securities Exchange (CSE).
  • Magical Brands Corp. updated its plans to list on the TSX Venture exchange through its three-cornered amalgamation with Good2Go Corp. (TSXV: GOTO.P).


Industry Developments

  • Ann Arbor decriminalizes magic mushrooms and psychedelic plants, making it one of just a handful of municipalities in the U.S. to do so. via WDIV
  • Psilocybin therapy is on the ballot in Oregon, which could make it one of the first states to legalize psychedelic medications. via The Mary Sue

Primary Sponsor

Karma Koala Podcast

Top Marijuana Blog